COVAXIN®
-
NEWS
COVAXIN® Only COVID-19 Vaccine To Have Demonstrated Efficacy Data From Phase III Clinical Trials Against Delta Variant At 65.2%
Bharat Biotech, a global leader in vaccine development and innovation, announced today that the safety and efficacy analysis data from…
Read More » -
NEWS
Bharat Biotech Concludes Final Analysis For COVAXIN® Efficacy From Phase 3 Clinical Trials
Bharat Biotech, a global leader in vaccine development and innovation, announced today safety and efficacy analysis data from Phase III…
Read More »